Feedback / Questions
Valcyte (valganciclovir) - Roche, Tanabe Pharma
Prevymis (letermovir) - Merck (MSD)
Letermovir vs Valganciclovir in CMV R+ Kidney Transplant
(clinicaltrials.gov)
-
May 7, 2026 -
P4 | N=300 | Not yet recruiting | Sponsor: Elisabeth Kincaide
New P4 trial
•
Cytomegalovirus Infection • Infectious Disease • Transplantation
http://clinicaltrials.gov/ct2/show/NCT07571135
May 7, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next